Dashboard
Manage Tickers

ARDXARDELYX, INC.

Nasdaq ardelyx.com


$ 8.47 $ -0.83 (-8.92 %)    

Wednesday, 08-May-2024 15:59:56 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 439.55 $ -0.26 (-0.06 %)
DIA $ 390.50 $ 1.74 (0.45 %)
SPY $ 517.10 $ 0.05 (0.01 %)
TLT $ 90.18 $ -0.55 (-0.61 %)
GLD $ 213.58 $ -0.63 (-0.29 %)
$ 8.48
$ 9.15
$ 0.00 x 0
$ 0.00 x 0
$ 8.41 - $ 9.17
$ 3.16 - $ 10.13
5,275,907
na
1.98B
$ 0.81
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-02-2024 03-31-2024 10-Q
2 02-22-2024 12-31-2023 10-K
3 10-31-2023 09-30-2023 10-Q
4 08-02-2023 06-30-2023 10-Q
5 05-03-2023 03-31-2023 10-Q
6 03-02-2023 12-31-2022 10-K
7 11-03-2022 09-30-2022 10-Q
8 08-04-2022 06-30-2022 10-Q
9 05-05-2022 03-31-2022 10-Q
10 02-28-2022 12-31-2021 10-K
11 11-12-2021 09-30-2021 10-Q
12 08-13-2021 06-30-2021 10-Q
13 05-06-2021 03-31-2021 10-Q
14 03-08-2021 12-31-2020 10-K
15 11-05-2020 09-30-2020 10-Q
16 08-06-2020 06-30-2020 10-Q
17 05-07-2020 03-31-2020 10-Q
18 03-06-2020 12-31-2019 10-K
19 11-06-2019 09-30-2019 10-Q
20 08-09-2019 06-30-2019 10-Q
21 05-07-2019 03-31-2019 10-Q
22 03-06-2019 12-31-2018 10-K
23 11-07-2018 09-30-2018 10-Q
24 08-07-2018 06-30-2018 10-Q
25 05-08-2018 03-31-2018 10-Q
26 03-14-2018 12-31-2017 10-K
27 11-07-2017 09-30-2017 10-Q
28 08-09-2017 06-30-2017 10-Q
29 05-05-2017 03-31-2017 10-Q
30 02-17-2017 12-31-2016 10-K
31 11-07-2016 09-30-2016 10-Q
32 08-08-2016 06-30-2016 10-Q
33 05-09-2016 03-31-2016 10-Q
34 03-04-2016 12-31-2015 10-K
35 11-12-2015 09-30-2015 10-Q
36 08-12-2015 06-30-2015 10-Q
37 05-12-2015 03-31-2015 10-Q
38 03-05-2015 12-31-2014 10-K
39 11-07-2014 09-30-2014 10-Q
40 08-08-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

ardelyx-to-present-additional-data-supporting-first-in-class-ibsrela-for-adults-with-irritable-bowel-syndrome-with-constipation-at-the-2024-digestive-disease-week-conference
Ardelyx To Present Additional Data Support...
05/07/2024 12:13:27

Ardelyx, Inc. (NASDAQ:ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovati...

ardx---analyzing-ardelyxs-short-interest
(ARDX) - Analyzing Ardelyx's Short Interest
05/06/2024 20:15:25

citigroup-maintains-buy-on-ardelyx-raises-price-target-to-14
Citigroup Maintains Buy on Ardelyx, Raises...
05/03/2024 21:49:34

Citigroup analyst Yigal Nochomovitz maintains Ardelyx (NASDAQ:ARDX) with a Buy and raises the price target from $13 to $14.

10-health-care-stocks-whale-activity-in-todays-session
10 Health Care Stocks Whale Activity In To...
05/03/2024 17:35:23

12-health-care-stocks-moving-in-fridays-intraday-session
12 Health Care Stocks Moving In Friday's I...
05/03/2024 16:31:47

amgen-posts-upbeat-results-joins-onespan-paylocity-holding-mercadolibre-and-other-big-stocks-moving-higher-on-friday
Amgen Posts Upbeat Results, Joins OneSpan,...
05/03/2024 14:15:59

wedbush-maintains-outperform-on-ardelyx-raises-price-target-to-15
Wedbush Maintains Outperform on Ardelyx, R...
05/03/2024 13:31:46

Wedbush analyst Laura Chico maintains Ardelyx (NASDAQ:ARDX) with a Outperform and raises the price target from $14 to $15.

Core News & Articles
Market-Moving News for May 3rd
05/03/2024 12:42:12

SPT: -32% | Sprout Social shares are trading lower after the company reported worse-than-expected Q1 revenue results. Multiple ...

12-health-care-stocks-moving-in-fridays-pre-market-session
12 Health Care Stocks Moving In Friday's P...
05/03/2024 12:06:34

why-apple-shares-are-trading-higher-by-6-here-are-20-stocks-moving-premarket
Why Apple Shares Are Trading Higher By 6%;...
05/03/2024 09:57:39

12-health-care-stocks-moving-in-thursdays-after-market-session
12 Health Care Stocks Moving In Thursday's...
05/02/2024 20:31:10

ardelyx-q1-2024-gaap-eps-011-beats-015-estimate-sales-46023m-beat-36397m-estimate
Ardelyx Q1 2024 GAAP EPS $(0.11) Beats $(0...
05/02/2024 20:05:42

Ardelyx (NASDAQ:ARDX) reported quarterly losses of $(0.11) per share which beat the analyst consensus estimate of $(0.15) by 26...

ardelyx-to-present-additional-data-for-xphozah-for-adults-with-chronic-kidney-disease-on-dialysis-at-national-kidney-foundation-2024-spring-clinical-meetings
Ardelyx To Present Additional Data For XPH...
05/01/2024 12:30:36

wedbush-maintains-outperform-on-ardelyx-raises-price-target-to-14
Wedbush Maintains Outperform on Ardelyx, R...
04/17/2024 16:54:08

Wedbush analyst Laura Chico maintains Ardelyx (NASDAQ:ARDX) with a Outperform and raises the price target from $13 to $14.

why-byrna-technologies-shares-are-trading-higher-by-around-7-here-are-other-stocks-moving-in-fridays-mid-day-session
Why Byrna Technologies Shares Are Trading ...
04/05/2024 17:06:12

Shares of Byrna Technologies Inc. (NASDAQ: BYRN) rose sharply during Friday’s session after the company reported better-than-ex...

a-closer-look-at-6-analyst-recommendations-for-ardelyx
A Closer Look at 6 Analyst Recommendations...
04/05/2024 12:00:20

leerink-partners-initiates-coverage-on-ardelyx-with-outperform-rating-announces-price-target-of-14
Leerink Partners Initiates Coverage On Ard...
04/05/2024 11:57:32

Leerink Partners analyst Roanna Ruiz initiates coverage on Ardelyx (NASDAQ:ARDX) with a Outperform rating and announces Pric...

watching-ardelyx-traders-circulate-analyst-comments-suggesting-congress-has-moved-hr-5074-into-the-markup-phase-which-should-dramatically-increase-the-pos-of-the-bill-getting-passed-should-lift-a-near-term-overhang-as-xphozahs-revenue-growth-should-be-preserved-into-2029-vs-2027-prior-we-see-10-15-upside
Watching Ardelyx; Traders Circulate Analys...
03/05/2024 19:52:05

whats-going-on-with-ardelyx-stock-after-earnings
What's Going On With Ardelyx Stock After E...
02/23/2024 20:37:33

Ardelyx reported ending 2023 with $184.3 million in cash and investments and expects full-year 2024 U.S. net product sales reve...

where-ardelyx-stands-with-analysts
Where Ardelyx Stands With Analysts
02/23/2024 19:00:48

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION